Preclinical Evaluation of [18 F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters

Contrast Media & Molecular Imaging
Andrea TestaMatteo Zanda

Abstract

The bile acid analogue [ 18 F]LCATD (LithoCholic Acid Triazole Derivative) is transported in vitro by hepatic uptake transporters such as OATP1B1 and NTCP and efflux transporter BSEP. In this in vivo "proof of principle" study, we tested if [ 18 F]LCATD may be used to evaluate drug-drug interactions (DDIs) caused by inhibition of liver transporters. Hepatic clearance of [ 18 F]LCATD in rats was significantly modified upon coadministration of rifamycin SV or sodium fusidate, which are known to inhibit clinically relevant uptake transporters (OATP1B1, NTCP) and canalicular hepatic transporters (BSEP) in humans. Treatment with rifamycin SV (total dose 62.5 mg·Kg-1) reduced the maximum radioactivity of [ 18 F]LCATD recorded in the liver from 14.2 ± 0.8% to 10.2 ± 0.9% and delayed t_max by 90 seconds relative to control rats. AUCliver 0-5 min, AUCbile 0-10 min and hepatic uptake clearance CLuptake,in vivo of rifamycin SV treated rats were significantly reduced, whereas AUCliver 0-30 min was higher than in control rats. Administration of sodium fusidate (30 mg·Kg-1) inhibited the liver uptake of [ 18 F]LCATD, although to a lesser extent, reducing the maximum radioactivity in the liver to 11.5 ± 0.3%. These preliminary results indicat...Continue Reading

References

Dec 1, 1985·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·C S Patlak, R G Blasberg
Jun 28, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K FattingerB Stieger
Nov 15, 2000·Seminars in Liver Disease·G A Kullak-UblickP J Meier
Jun 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Stephan R VavrickaKarin Fattinger
Jul 11, 2002·Biochemical Pharmacology·Konrad A BodeDietrich Keppler
Nov 19, 2009·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·P SharmaD Surry
Aug 19, 2010·The Journal of Pharmacology and Experimental Therapeutics·Tadayuki TakashimaYasuyoshi Watanabe
Oct 4, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sarah DawsonJ Gerald Kenna
Mar 29, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Kim FrischSusanne Keiding
Apr 28, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Pradeep SharmaDominic Surry
Feb 27, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Sara NeytFilip De Vos
Aug 9, 2013·The Journal of Pharmacology and Experimental Therapeutics·Tomotaka ShingakiYasuyoshi Watanabe
Jun 25, 2014·Molecular Pharmaceutics·Jiake HeJashvant D Unadkat
Jun 3, 2015·Molecular Pharmaceutics·Andrea TestaPradeep Sharma
Feb 19, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Heather EngAmit S Kalgutkar
Mar 12, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Michael SørensenSusanne Keiding
Jun 22, 2016·Clinical Pharmacology and Therapeutics·A MannS Eyal
Jul 8, 2016·Journal of Clinical Pharmacology·Houfu Liu, Jasminder Sahi
Jul 8, 2016·Journal of Clinical Pharmacology·Oliver Langer
Jul 8, 2016·Journal of Clinical Pharmacology·Mitesh PatelMaciej J Zamek-Gliszczynski

❮ Previous
Next ❯

Software Mentioned

Excel
OSEM
PMOD
FORE

Related Concepts

Related Feeds

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.

© 2022 Meta ULC. All rights reserved